AB1481 EMERALD STUDY DESIGN: A TWO-COHORT, OPEN-LABEL, SINGLE-ARM STUDY OF EMAPALUMAB, AN ANTI–INTERFERON-Γ (IFNΓ) MONOCLONAL ANTIBODY, IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) IN RHEUMATIC DISEASES